VSBC — Vitaspring Biomedical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Vitaspring Biomedical, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
R2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.91 | -4.16 | -1.12 | -0.775 | -0.415 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.167 | 0.428 | 0.341 | 0.2 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.01 | 3.65 | 0.727 | 0.551 | 0.403 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.085 | -0.078 | -0.035 | -0.015 | -0.003 |
| Capital Expenditures | -0.073 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.073 | 0 | — | — | — |
| Financing Cash Flow Items | — | — | 0.005 | 0.015 | 0.004 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.05 | 0 | 0.005 | 0.015 | 0.004 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.062 | -0.078 | -0.03 | 0 | 0.002 |